EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Journal of Controlled Release

Description
official journal of the Controlled Release
Society and of the Japanese Society of Drug Delivery Systems

 

Status
active
Indexing
BIOSIS; CAB Abstracts; Chemical Abstracts; Current Contents/Life Sciences; EMBASE; International Pharmaceutical Abstracts; MEDLINE®;
Polymer Contents; Science Citation Index; Scopus
Subject

Source type
Journal
Publisher
ISBN ISSN
0168-3659
First volume
1
Last volume
162+
Homepage
Description
The journal publishes innovative, original research involving the controlled release and delivery of drugs and other biologically active agents. The terms "controlled release" and "delivery" are used in their broadest sense to include mechanisms such as diffusion, chemical and enzymatic reactions, dissolution, osmosis, targeting, as well as the utilization and manipulation of biological processes. A broad spectrum of studies dealing with all aspects of controlled release and delivery, including gene delivery, tissue engineering and diagnostic agents, is encouraged. The use of prodrugs and carriers such as water-soluble polymers, micro and nanoparticles, liposomes and micelles is included in the scope.

In addition to original full length papers and reviews, the journal includes reports of future meetings and announcements pertaining to the activities of the Controlled Release Society.


Related links:









Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )